Claims
| Claim | Type | Assessment | Score | Review checks | References |
|---|---|---|---|---|---|
| In a randomized controlled trial of 249 physicians in Indonesia, Kenya, and the Netherlands, GPT-4o access improved clinical-performance scores relative to control by 18 percentage points in Kenya, 10.7 in Indonesia, and 7.2 in the Netherlands under controlled conditions; harms were not assessed. | QUANTITATIVE | Supported | 0.9468 | 1 of 4 | 119 |